1. Home
  2. CMTL vs COEP Comparison

CMTL vs COEP Comparison

Compare CMTL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.21

Market Cap

64.4M

Sector

Technology

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$15.85

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
COEP
Founded
1967
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.4M
100.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CMTL
COEP
Price
$3.21
$15.85
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
278.6K
74.3K
Earning Date
01-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
$500,996.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$2.31
52 Week High
$4.88
$21.41

Technical Indicators

Market Signals
Indicator
CMTL
COEP
Relative Strength Index (RSI) 58.52 47.72
Support Level $3.00 $15.40
Resistance Level $3.32 $16.80
Average True Range (ATR) 0.20 1.57
MACD 0.01 -0.11
Stochastic Oscillator 88.33 20.64

Price Performance

Historical Comparison
CMTL
COEP

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: